Update on KHK4083: A phase 1 study in subjects with atopic dermatitis

December 3, 2018

On-demand replay (audio) will be available from Dec. 6, 2018 to Dec. 5, 2019.

Investor event 2018

Update on burosumab (KRN23): Clinical and regulatory updates, and pre-launch activities in the US and EU

October 27, 2017